Powerup's comment on PMCK. All Comments

Powerup
Like · Reply
Maybank IBG Research initiate call buy with target price 0.350 highlighting the company’s long-term growth prospects within northern Malaysia’s underserved private healthcare market
Powerup
Maybank Investment Bank Research said better patient numbers, stable inpatient revenue and the upcoming 90-bed PMC Kulim hospital are expected to drive the company’s growth, with net profit projected to grow at an 11.5% CAGR from FY25 to FY28
Like · 4 weeks · translate
Kuromi
net profit 11.5% CAGR quite good eh
Like · 4 weeks · translate
David Victor
actuall CAGR 11.5% is consider high or low for this industry?
Like · 3 weeks · translate
Powerup
it’s actually high, cause the average CAGR for healthcare industry is around 6-9%
Like · 3 weeks · translate
David Victor
I see, and the CAGR is not yet include the future growth coming from the new hospital that is estimated to complete in year 2028 right?
Like · 3 weeks · translate
Powerup
yes, the current CAGR I think not yet factor in the future earning contribute from the new hospital
Like · 3 weeks · translate
CloudDrifter
Maybank IB expects PMCK’s long-term net profit CAGR to climb to 17.3% between FY28 and FY35.
Like · 1 week · translate
Kang1995
17.6% of cagr can already compete with some of the technology counter already
Like · 5 days · translate
Jason Wan
but dont forget, tech counters are often hit and miss, unlike healthcare counter like PMCK
Like · 5 days · translate
Kang1995
yep, and the volatility is too high for tech for me, healthcare segment more suit my personality, slow but steady over the long run
Like · 4 days · translate
Kuromi
if stock selection done right, the return of healthcare stock can outperform tech stock easily
Like · 4 days · translate
Powerup
indeed slow and steady for healthcare like hospital segment, like ihh and kpj
Like · 3 days · translate
Fiona Auery
but what differs them from their peers is they are still in expansion phase, so big potential upside there
Like · 3 days · translate